Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
CH0461929603
Tue, 23.12.2025
Xlife Sciences AG
Xlife Sciences AG
/ Key word(s): Miscellaneous
Xlife Sciences AG Announces Transition to the Main Segment of SIX Swiss Exchange to Strengthen Market Presence
23.12.2025 / 07:00 CET/CEST
Zurich, 23rd of December 2025: Xlife Sciences AG (SIX: XLS) today announced that its Board of Directors has resolved to move from the S [ … ]
Fri, 12.12.2025
Xlife Sciences AG
Xlife Sciences AG
/ Key word(s): Alliance
Award-Winning Liver PET Tracer Highlights the Strength of Our Innovation Portfolio
12.12.2025 / 08:30 CET/CEST
Zurich, 12th of December 2025: Xlife Sciences AG (SIX:XLS) is pleased to announce that DAZAmed, the world’s first liver-specific PET tracer, developed in strategic coop [ … ]
Mon, 08.12.2025
Xlife Sciences AG
Zurich, 8th of December 2025: Xlife Sciences AG (SIX: XLS) today announced that Grupo Landsteiner has signed a binding framework to acquire 12 of Xlife Sciences’ advanced biotech, medtech and digital health projects for a total of USD 450 million, payable in shares of Grupo Landsteiner. The transaction represents a strategic exit for Xlife Sciences [ … ]
Mon, 01.12.2025
Xlife Sciences AG
Zurich, 1st of December2025: Xlife Sciences AG (SIX: XLS), together with saniva diagnostics GmbH, today announced a landmark achievement: NeuroMex is the world’s first certified and clinically validated medical device for early detection of Alzheimer’s disease based on the recording of motor responsiveness. It has now successfully completed pivotal [ … ]
Fri, 28.11.2025
Xlife Sciences AG
Xlife Sciences AG
/ Key word(s): IPO/Merger
Xlife Sciences AG Provides Update on VERAXA Biotech AG’s NASDAQ Listing Process Following U.S. Government Shutdown
28.11.2025 / 13:10 CET/CEST
Zurich, 28th of November 2025: Xlife Sciences AG («Xlife Sciences», SIX: XLS), a leading incubator and value creator in the life scien [ … ]
Thu, 16.10.2025
Xlife Sciences AG
Xlife Sciences AG
/ Key word(s): ESG
Xlife Sciences AG Publishes 2024 ESG Report: Sustainable Value Creation as a Strategic Core
16.10.2025 / 07:00 CET/CEST
Zurich, 16th of October 2025: Xlife Sciences AG (SIX: XLS) today announced the publication of its 2024 ESG Report. The report documents the company’s progress in in [ … ]
Tue, 23.09.2025
Xlife Sciences AG
Zurich, 23rd of September 2025: Xlife Sciences AG (SIX: XLS) today published its Half-Year Report 2025. The first half of the year was marked by consistent preparation for the capital markets. With the filing of the F-4 prospectus by VERAXA Biotech AG, a decisive step toward a NASDAQ listing has been taken and a milestone for both VERAXA and Xlife [ … ]
Thu, 17.07.2025
Xlife Sciences AG
Xlife Sciences AG
/ Key word(s): IPO/Merger
Xlife Sciences AG’s Portfolio Company, VERAXA Biotech AG, Takes Key Step Toward NASDAQ Listing with Filing of Form F-4
17.07.2025 / 07:00 CET/CEST
The filing demonstrates continued momentum in VERAXA’s public market journey and billion-dollar valuation
Zurich, 17th of July 20 [ … ]
Tue, 24.06.2025
Xlife Sciences AG
Xlife Sciences AG
/ Key word(s): AGMEGM
Xlife Sciences AG: Successful General Meeting and Growth Prospects for 2025
24.06.2025 / 18:00 CET/CEST
Zurich, 24th of June 2025: At today’s Annual General Meeting of Xlife Sciences AG (SIX: XLS), all proposals of the Board of Directors were approved. A total of 3’181’966 voting [ … ]
Mon, 16.06.2025
Xlife Sciences AG
Xlife Sciences AG
/ Key word(s): Alliance/Partnership
Strategic Collaboration Between Xlife Sciences AG, Huraypositive Corp., and OncoMASTER Inc. to Boost Digital Health and Precision Oncology in Asia
16.06.2025 / 16:00 CET/CEST
Zurich, 16th of June 2025: Xlife Sciences AG («Xlife Sciences»SIX: XLS), a Swiss-based incub [ … ]
